What is the current Hormonal Contraceptive market size?

The Hormonal Contraceptive market size is approximately USD 13.6 billion as of 2022.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 6.2% from 2023 to 2030.

What are the key drivers of the Hormonal Contraceptive market?

Increasing awareness and rising demand for **effective** birth control methods drive the market.

What are the major challenges facing the Hormonal Contraceptive market?

Side effects and limited access to **contraceptive** options in developing regions are major challenges.

Which regions are leading the Hormonal Contraceptive market?

North America and Europe are the leading regions due to high **contraceptive** usage rates.

Who are the top companies in the Hormonal Contraceptive market?

Top companies include Pfizer, Merck, and Bayer, offering a range of **hormonal** products.

What future opportunities exist in the Hormonal Contraceptive market?

Emerging markets and innovative **contraceptive** technologies offer growth opportunities.

How is technology impacting the Hormonal Contraceptive market?

Advances in **contraceptive** technology are improving efficacy and user experience.

What is the current regulatory landscape for the Hormonal Contraceptive market?

Stringent regulations and safety standards govern the **hormonal** product approval process.

What is the future outlook for the Hormonal Contraceptive market?

The market is expected to experience steady growth due to increasing **contraceptive** demand.

Which Companies Lead the Hormonal Contraceptive Market in 2026?

Hormonal Contraceptive by Application (Hospitals, Household, Clinics), by Types (Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Transdermal Patches, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Hormonal Contraceptive Market Size | CAGR 5.2 Forecast 2033

Which Companies Lead the Hormonal Contraceptive Market in 2026?

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Hormonal Contraceptive Market Overview

The Hormonal Contraceptive market refers to the industry that provides products and services for preventing pregnancy through hormonal means. As the Hormonal Contraceptive market size is expected to witness significant growth, the growth outlook and market forecast are crucial for industry stakeholders. The global Hormonal Contraceptive market is estimated to be approximately $24.8 billion in 2025, with a CAGR of around 5.5% during the forecast period from 2026 to 2033. The industry expansion is driven by factors such as increasing awareness about reproductive health, rising demand for contraceptive methods, and advancements in hormonal contraceptive technology. Key forces shaping the industry include technology shifts towards more efficient and user-friendly products, regulations regarding the approval and distribution of hormonal contraceptives, and consumer behavior trends such as the growing preference for non-invasive and reversible methods.

Loading chart…

The largest region in the Hormonal Contraceptive market is North America, accounting for a significant share of the global market. The fastest-growing region is expected to be the Asia-Pacific region, driven by increasing awareness and demand for hormonal contraceptives. The industry is expected to witness significant growth during the forecast period, driven by factors such as technology shifts, regulations, and consumer behavior trends. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest developments and trends in the Hormonal Contraceptive market.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	18.52 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Ansell Limited; Bayer AG; Church and Dwight Co; Johnson and Johnson; Mayer Laboratories; Merck and Co; Mylan N.V.; Pfizer; Teva Pharmaceutical Industries; The Female Health Company; Organon International; Afaxys
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Hormonal Contraceptive market is experiencing significant transformations, driven by various factors. The market dynamics are crucial in understanding the current and future trends in the industry.

Growth Drivers2 items

Increasing awareness about Hormonal Contraceptive market size and its benefits among women, particularly in developing countries, is driving the demand for these products, with a significant growth forecast expected in the coming years.

Advancements in technology have led to the development of more effective and convenient Hormonal Contraceptive methods, such as transdermal patches and vaginal rings, which are gaining popularity among users.

Restraints2 items

Stringent regulatory requirements and strict approval processes for new Hormonal Contraceptive products are limiting the entry of new players in the market and hindering the growth forecast of existing ones.

Side effects associated with Hormonal Contraceptive methods, such as weight gain and mood swings, are a major concern for users, which can negatively impact the demand for these products and affect the overall Hormonal Contraceptive market size.

Opportunities2 items

The growing demand for Hormonal Contraceptive methods in emerging economies presents a significant opportunity for manufacturers to expand their product offerings and increase their market share, ultimately contributing to the growth forecast of the Hormonal Contraceptive market.

The development of novel Hormonal Contraceptive products, such as contraceptive implants and injections, is expected to drive innovation in the market and attract new users, further increasing the Hormonal Contraceptive market size.

Challenges2 items

The Hormonal Contraceptive market is highly competitive, with several established players, making it challenging for new entrants to gain traction and increase their Hormonal Contraceptive market size.

Fluctuations in raw material prices and supply chain disruptions can impact the production costs and availability of Hormonal Contraceptive products, affecting the overall growth forecast of the market.

Market Segmentation

Loading chart…

The Hormonal Contraceptive market can be segmented based on Application, which includes subtypes such as contraception, hormone replacement therapy, and treatment of menstrual disorders. Each of these subtypes contributes to the overall market size, with contraception being the largest segment. The application segment contributes to the overall market size by providing a wide range of options for users to manage their reproductive health, making it a crucial aspect of the Hormonal Contraceptive segmentation.

The Types segment of the Hormonal Contraceptive market includes subtypes such as combined oral contraceptives, progestin-only pills, patches, vaginal rings, and injectables. Each of these subtypes has its own unique characteristics, advantages, and disadvantages, catering to different user needs and preferences. Understanding the different types of hormonal contraceptives is essential for market taxonomy, as it helps to identify trends, opportunities, and challenges in the market, ultimately contributing to the growth of the Hormonal Contraceptive market.

Hormonal Contraceptive Segmentation Breakdown11 items

Application

Hospitals

Household

Clinics

Types

Oral Contraceptive Pills

Injectable Birth Control

Emergency Contraceptive Pills

Vaginal Rings

Transdermal Patches

Others

Regional Insights

Loading chart…

The Hormonal Contraceptive market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, and Latin America being the fastest-growing region. Key drivers for North America include increased adoption of hormonal contraceptives, favorable policies, and investments in healthcare infrastructure. In Europe, demographics, ecosystem maturity, and regulatory frameworks are driving the market.

In Asia Pacific, growing infrastructure, government initiatives, and rising awareness about hormonal contraceptives are driving the market. Latin America's growth is driven by expanding healthcare access, increasing female population, and improving economic conditions. The Middle East & Africa region is driven by government investments in healthcare, rising population, and growing awareness about hormonal contraceptives. The regional forecast indicates a significant growth in the Hormonal Contraceptive market, driven by these key factors.

Competitive Landscape

The Hormonal Contraceptive market is moderately consolidated, with a mix of global players and local/regional companies competing on pricing, distribution, product innovation, certifications, and regulatory approvals. The Hormonal Contraceptive competitive landscape is driven by these factors, which enable companies to differentiate themselves and establish a strong market presence. Global players tend to dominate the market, but local companies are also significant, particularly in emerging economies.

Companies in the Hormonal Contraceptive market employ various strategies to differentiate themselves, such as M&A, partnerships, product launches, expansion, R&D, and localization. They focus on technology, service model, channel strength, customization, and cost advantages to stay competitive. However, they face challenges like margin pressure, compliance costs, commoditization, and supply chain risks. To overcome these challenges, companies must develop effective strategies and leverage their strengths to maintain a competitive edge.

Ansell Limited: regional expansion

Bayer AG: innovation pipeline

Church and Dwight Co: premium pricing

Johnson and Johnson: vertical integration

Mayer Laboratories: OEM tie-ups

Merck and Co: local manufacturing

Key Hormonal Contraceptive Companies12 items

Ansell Limited

Bayer AG

Church and Dwight Co

Johnson and Johnson

Mayer Laboratories

Merck and Co

Mylan N.V.

Pfizer

Teva Pharmaceutical Industries

The Female Health Company

Organon International

Afaxys

Market Ecosystem

The Hormonal Contraceptive ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of hormonal contraceptive products, with various participants contributing to the overall value chain analysis.

Raw material suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing hormonal contraceptive products

Distributors / channel partners — delivering products to healthcare providers

Service providers / after-sales — offering support and guidance to end users

End users / buyers — healthcare providers and individuals using hormonal contraceptives

Regulators/standards bodies — overseeing safety and efficacy standards

Data/analytics providers — tracking usage and outcomes to inform product development

In the Hormonal Contraceptive ecosystem, control points are held by regulators and standards bodies, influencing adoption through safety and efficacy approvals. Dependency risks arise from input constraints, such as raw material availability, and standards compliance. Switching costs and partnerships also play a role, as manufacturers and distributors form relationships to ensure product availability. The ecosystem differs by region, with varying regulatory requirements and healthcare infrastructure influencing the flow of value and potential bottlenecks.

Recent Industry Insights

The Hormonal Contraceptive industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between pharmaceutical companies have led to the creation of innovative products and technologies. Notable mergers and acquisitions have also taken place, resulting in the expansion of product portfolios and market reach. Furthermore, several product launches have occurred, including new contraceptive methods and devices. Regulatory changes have also impacted the industry, with updates to guidelines and approvals for new products. A shift in consumer trends has been observed, with a growing demand for convenient and _user-friendly_ contraceptive options. Additionally, funding rounds and expansions have been announced, supporting the growth of companies in the Hormonal Contraceptive market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Hormonal Contraceptive market. The market attractiveness is moderate, driven by increasing awareness and demand for effective contraceptive methods. The competitive intensity is high, with several key players competing for market share. The long-term Hormonal Contraceptive market outlook is promising, with opportunities for growth in emerging markets. The innovation landscape is characterized by ongoing research and development of new products and technologies. However, the demand-supply balance is a key risk factor, with fluctuations in supply chain and regulatory environments affecting market stability. Overall, our analysis highlights the need for strategic planning and adaptability in this dynamic market.

11 items

1. Executive Summary

2. Hormonal Contraceptive Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Hormonal Contraceptive Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Hormonal Contraceptive Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Household

6.1.3. Clinics

6.2. Global Hormonal Contraceptive Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Oral Contraceptive Pills

6.2.2. Injectable Birth Control

6.2.3. Emergency Contraceptive Pills

6.2.4. Vaginal Rings

6.2.5. Transdermal Patches

6.2.6. Others

6.3. Global Hormonal Contraceptive Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Hormonal Contraceptive Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Hormonal Contraceptive Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Hormonal Contraceptive Market Competition by Key Manufacturers

8.1. Global Hormonal Contraceptive Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Hormonal Contraceptive: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Ansell Limited

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Bayer AG

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Church and Dwight Co

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Johnson and Johnson

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Mayer Laboratories

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Merck and Co

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Mylan N.V.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Pfizer

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Teva Pharmaceutical Industries

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. The Female Health Company

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Organon International

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Afaxys

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Hormonal Contraceptive Market

Figure 4: Global Hormonal Contraceptive Market: Drivers

Figure 5: Global Hormonal Contraceptive Market: Challenges

Figure 6: Global Hormonal Contraceptive Market: Trends

Figure 7: Global Hormonal Contraceptive Market: Opportunity

Figure 8: Global Hormonal Contraceptive Market: Restraint

Figure 9: Global Hormonal Contraceptive Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Hormonal Contraceptive Market Value (USD Million) By Region

Figure 15: Global Hormonal Contraceptive Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Hormonal Contraceptive Market Value (USD Million) By Region

Figure 23: Global Hormonal Contraceptive Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Hormonal Contraceptive Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Hormonal Contraceptive Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Hormonal Contraceptive Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Hormonal Contraceptive Market Value (USD Million) By Region

Table 10: Global Hormonal Contraceptive Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Hormonal Contraceptive Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Hormonal Contraceptive Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Hormonal Contraceptive Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Ansell Limited Basic Information And Sales Area

Table 31: Ansell Limited. Products Portfolio

Table 32: Bayer AG Basic Information And Sales Area

Table 33: Bayer AG. Products Portfolio

Table 34: Church and Dwight Co Basic Information And Sales Area

Table 35: Church and Dwight Co. Products Portfolio

Table 36: Johnson and Johnson Basic Information And Sales Area

Table 37: Johnson and Johnson. Products Portfolio

Table 38: Mayer Laboratories Basic Information And Sales Area

Table 39: Mayer Laboratories. Products Portfolio

Table 40: Merck and Co Basic Information And Sales Area

Table 41: Merck and Co. Products Portfolio

Table 42: Mylan N.V. Basic Information And Sales Area

Table 43: Mylan N.V.. Products Portfolio

Table 44: Pfizer Basic Information And Sales Area

Table 45: Pfizer. Products Portfolio

Table 46: Teva Pharmaceutical Industries Basic Information And Sales Area

Table 47: Teva Pharmaceutical Industries. Products Portfolio

Table 48: The Female Health Company Basic Information And Sales Area

Table 49: The Female Health Company. Products Portfolio

Table 50: Organon International Basic Information And Sales Area

Table 51: Organon International. Products Portfolio

Table 52: Afaxys Basic Information And Sales Area

Table 53: Afaxys. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Hormonal Contraceptive Market Value (USD Million) By Region

Table 59: Global Hormonal Contraceptive Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Hormonal Contraceptive Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	18.52 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Ansell Limited; Bayer AG; Church and Dwight Co; Johnson and Johnson; Mayer Laboratories; Merck and Co; Mylan N.V.; Pfizer; Teva Pharmaceutical Industries; The Female Health Company; Organon International; Afaxys
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options